Literature DB >> 22677431

A threshold model for the susceptibility to transfusion-related acute lung injury.

U J Sachs1.   

Abstract

Transfusion-related acute lung injury (TRALI) is a serious, often life-threatening pulmonary transfusion reaction characterized by non-cardiogenic lung oedema, hypoxemia and respiratory distress in temporal association with blood transfusion. The critical mechanism in TRALI is the sudden increase in permeability of the pulmonary endothelium and the subsequent, often extensive shift of fluid into the alveolae. The rapid clinical recovery seen in most patients makes it likely that this is a temporary phenomenon. Reactive oxygen species released by neutrophils or other cells are attractive candidate mediators of this process. There is experimental and clinical evidence that several pathways can induce barrier breakdown in TRALI, a concept known as the threshold model of TRALI. Surprisingly, neutrophils may not always be required. Other cells may play a role as multipliers or attenuators of TRALI, depending on recipient-related and transfusion-related factors involved. This review will summarize recent findings on pathophysiology, with a focus on newly discovered or disenchanted recipient-related and transfusion-related risk factors for TRALI and will present the threshold model of TRALI as a unifying concept on how TRALI develops.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22677431     DOI: 10.1016/j.tracli.2012.03.003

Source DB:  PubMed          Journal:  Transfus Clin Biol        ISSN: 1246-7820            Impact factor:   1.406


  7 in total

1.  Immunoglobulin (Ig)G purified from human sera mirrors intravenous Ig human leucocyte antigen (HLA) reactivity and recognizes one's own HLA types, but may be masked by Fab complementarity-determining region peptide in the native sera.

Authors:  M H Ravindranath; P I Terasaki; C Y Maehara; V Jucaud; S Kawakita; T Pham; W Yamashita
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

2.  Intra-vital Observation of Lung Water Retention Following Intravenous Injection of Anti-MHC-class I (H-2K) Monoclonal Antibody in Mice.

Authors:  Hideyuki Ochi; Takehiko Iijima; Akira Ushiyama
Journal:  In Vivo       Date:  2019 Sep-Oct       Impact factor: 2.155

3.  Experimental prestorage filtration removes antibodies and decreases lipids in RBC supernatants mitigating TRALI in vivo.

Authors:  Christopher C Silliman; Marguerite R Kelher; Samina Y Khan; Monica LaSarre; F Bernadette West; Kevin J Land; Barbara Mish; Linda Ceriano; Samuel Sowemimo-Coker
Journal:  Blood       Date:  2014-04-18       Impact factor: 22.113

4.  A prophylactic fresh frozen plasma transfusion leads to a possible case of transfusion-related acute lung injury.

Authors:  Debasree Banerjee; Rashid Hussain; Jeffrey Mazer; Gerardo Carino
Journal:  BMJ Case Rep       Date:  2014-07-21

Review 5.  Risk factors, management and prevention of transfusion-related acute lung injury: a comprehensive update.

Authors:  Susan A Kuldanek; Marguerite Kelher; Christopher C Silliman
Journal:  Expert Rev Hematol       Date:  2019-07-16       Impact factor: 2.929

6.  Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors.

Authors:  Luciana Teofili; Maria Bianchi; Bruno A Zanfini; Stefano Catarci; Rossella Sicuranza; Serena Spartano; Gina Zini; Gaetano Draisci
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-10-22       Impact factor: 2.576

Review 7.  HLA Class Ia and Ib Polyreactive Anti-HLA-E IgG2a Monoclonal Antibodies (TFL-006 and TFL-007) Suppress Anti-HLA IgG Production by CD19+ B Cells and Proliferation of CD4+ T Cells While Upregulating Tregs.

Authors:  Mepur H Ravindranath
Journal:  J Immunol Res       Date:  2017-05-28       Impact factor: 4.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.